filovirida
famili
consist
three
genera
marburgviru
ebolaviru
newli
identifi
cuevaviru
within
ebolaviru
genu
five
speci
includ
zair
ebolaviru
sudan
ebolaviru
bundibugyo
ebolaviru
forest
ebolaviru
reston
ebolaviru
filovirus
first
identifi
caus
agent
hemorrhag
fever
syndrom
marburg
germani
nine
year
later
first
two
ebolavirus
describ
democrat
republ
congo
formerli
zair
sudan
sinc
ebola
viru
diseas
outbreak
infect
thousand
mean
case
fatal
rate
human
hartman
et
al
recent
ebola
viru
diseas
outbreak
west
africa
began
march
thu
far
caus
confirm
probabl
case
case
fatal
rate
latest
inform
see
http
wwwwhointcsrdiseaseebolaen
ebola
particl
envelop
filament
contain
monopartit
negativesens
rna
genom
though
ebola
initi
target
macrophag
dendrit
cell
abl
infect
almost
cell
type
except
lymphocyt
woollewi
bate
yang
et
al
viru
particl
propos
attach
host
cell
multipl
plasma
membran
surfaceexpress
protein
eg
ctype
lectin
dcsign
integrin
axl
alvarez
et
al
baribaud
et
al
kondratowicz
et
al
lin
et
al
schornberg
et
al
shimojima
et
al
simmon
et
al
takada
et
al
attach
plasma
membran
viral
envelop
glycoprotein
induc
particl
uptak
via
macropinocytosi
induct
macropinocytosi
appear
depend
action
cell
surfac
protein
includ
axl
aleksandrowicz
et
al
brindley
et
al
hunt
et
al
mollertank
et
al
mulherkar
et
al
nanbo
et
al
quinn
et
al
saeed
et
al
shimojima
et
al
shimojima
et
al
wen
et
al
uptak
macropinosom
particl
travel
lowph
compart
late
endosom
lysosom
viral
envelop
glycoprotein
gp
proteolyt
cleav
endosom
cystein
proteas
ie
cathepsin
b
l
cleavag
remov
heavili
glycosyl
region
gp
chandran
et
al
dube
et
al
hood
et
al
misasi
et
al
schornberg
et
al
expos
domain
gp
bind
specif
endosomallysosom
resid
filoviru
receptor
niemannpick
protein
carett
et
al
et
al
though
current
evid
suggest
bind
may
suffici
trigger
fusion
viral
cellular
membran
miller
et
al
yet
unclear
whether
addit
host
protein
intracellular
condit
necessari
eg
reduc
condit
alter
ph
addit
proteas
cleavag
brecher
et
al
chandran
et
al
figur
left
viral
intern
cell
membran
fuse
viru
particl
uncoat
antigenom
transcrib
mrna
use
nucleocapsidassoci
viral
protein
viru
genom
consist
seven
viral
nucleoprotein
np
matrix
protein
rnadepend
rna
polymeras
l
glycoproteinwhich
transcrib
mrna
result
product
least
ten
protein
transcript
genom
mediat
via
complex
viral
polymeras
l
bound
npcoat
genom
bharat
et
al
hartlieb
et
al
hartlieb
et
al
modrof
et
al
hlberger
et
al
sanchez
kiley
sanchez
et
al
phosphoryl
lead
dissoci
complex
signal
switch
transcript
replic
biedenkopf
et
al
martinez
et
al
follow
switch
viru
genom
replic
coat
np
hlberger
et
al
assembl
l
associ
ribonucleoprotein
complex
interact
ribonucleoprotein
associ
matrix
protein
viral
particl
extrud
plasma
membran
within
lipid
raft
microdomain
region
stahelin
figur
left
sneak
trash
apoptot
mimicri
ebolaviru
particl
micron
length
make
difficult
virus
enter
via
classic
clathrinor
caveolinmedi
endocytosi
pathway
perhap
explain
requir
macropinocytot
uptak
interestingli
increas
amount
phosphatidylserin
ps
may
present
surfac
ebolaviruslik
particl
jemiel
et
al
mollertank
et
al
ps
lipid
primarili
present
inner
leaflet
plasma
membran
zachowski
upon
cell
death
via
apoptosi
ps
expos
outer
leaflet
plasma
membran
apoptot
bodi
alert
nearbi
cell
includ
phagocyt
cell
begin
eat
debri
via
macropinocytosi
process
mediat
axl
induc
inflammatori
respons
biermann
et
al
morizono
chen
rska
et
al
suggest
possibl
similar
larg
virus
vaccinia
viru
mercer
heleniu
ebola
may
induc
macropinocyt
uptak
appear
apoptot
bodi
phagocyt
cell
apoptot
mimicri
antiinflammatori
induc
rapid
uptak
larg
viru
cell
thu
avoid
humor
cell
surfac
immun
factor
snip
alarm
wire
prevent
interferon
alarm
evas
host
innat
immun
respons
particular
import
virus
mani
evolv
mechan
circumv
innat
immun
ebola
inhibit
type
type
ii
interferon
respons
target
cell
especi
macrophag
monocyt
dendrit
cell
ultim
result
defect
dendrit
cell
matur
diminish
tcell
activ
prolifer
along
apoptosi
lead
lymphopenia
key
characterist
ebola
viru
diseas
studi
anim
model
tissu
cultur
suggest
pathogenesi
interferon
antagon
link
cilloniz
et
al
ebihara
et
al
hartman
et
al
hartman
et
al
mateo
et
al
prin
et
al
reid
et
al
viral
polymeras
cofactor
function
rna
synthesi
propos
link
l
np
addit
role
play
promin
role
ebola
inhibit
b
interferon
induct
multipl
mechan
rigi
innat
pattern
recognit
receptor
detect
foreign
cytosol
rna
rigi
recogn
triphosph
left
viru
particl
attach
cell
surfac
induc
macropinocytosi
viru
uptak
possibl
use
apoptot
mimicri
suppress
inflammatori
respons
particl
brought
low
ph
compart
cleav
cystein
proteas
reveal
receptorbind
domain
rbd
follow
fusion
uncoat
viral
genom
transcrib
mrna
viral
protein
produc
eventu
signal
begin
genom
replic
occur
follow
particl
assembl
bud
express
secret
sgp
serv
antibodi
decoy
antibodi
gener
gp
viral
protein
express
mediat
innat
immun
avoid
cell
type
left
interfer
signal
induct
interferon
addit
block
rnai
respons
viral
gene
express
right
act
inhibit
type
ii
interferon
ifn
signal
prevent
interferoninduc
gene
express
antigenpres
cell
block
enhanc
antigen
present
cell
bluntend
rna
sens
long
doublestrand
rna
dsrna
signal
via
downstream
adaptor
aka
mav
visa
cardif
result
nfkb
activ
subsequ
express
type
interferon
proinflammatori
cytokin
activ
result
signal
cascad
phosphoryl
tankbind
kinas
ikb
chiang
et
al
earli
experi
determin
disrupt
rigi
pathway
prevent
phosphoryl
basler
et
al
basler
et
al
later
shown
interact
ntermin
kinas
domain
prevent
phosphoryl
act
decoy
substrat
kinas
furthermor
bind
prevent
interact
protein
includ
prin
et
al
net
result
interact
inhibit
induct
gene
interferon
respons
promot
addit
downstream
event
rigi
pathway
interact
dsrna
prevent
rigi
respons
rdena
et
al
structur
biochem
studi
reveal
contain
ctermin
interferon
inhibitori
domain
iid
two
cluster
basic
amino
acid
one
cluster
center
residu
particip
bind
dsrna
analysi
reveal
bind
bluntend
dsrna
manner
similar
seen
rigi
rdena
et
al
leung
et
al
leung
et
al
structur
studi
dsrna
bind
consist
find
prevent
rigi
respons
observ
rnabound
unbound
structur
reveal
abl
bind
phosphat
backbon
dsrna
endcap
rna
dimer
mutat
basic
patch
center
abrog
dsrna
bind
structur
analysi
suggest
mutat
disrupt
dimer
kimberlin
et
al
experi
use
recombin
virus
incorpor
mutant
show
attenu
virul
impair
viru
growth
interferon
antagon
suggest
iid
bind
dsrna
dimer
play
key
role
viru
life
cycl
pathogenesi
hartman
et
al
hartman
et
al
kimberlin
et
al
prin
et
al
interestingli
comparison
iid
pathogen
zair
ebolaviru
reston
ebolavirusthu
far
pathogen
monkeysrev
slight
decreas
interferon
antagon
dsrna
bind
reston
howev
decreas
appear
contribut
significantli
differ
virul
zair
reston
virus
leung
et
al
furthermor
comparison
structur
zair
reston
reveal
substanti
differ
dsrna
recognit
mechan
kimberlin
et
al
togeth
data
suggest
addit
viral
factor
like
play
role
differenti
host
respons
two
virus
recent
found
interact
pkr
activ
pact
fabozzi
et
al
addit
activ
rna
silenc
pkr
activ
pact
bind
activ
rigi
subsequ
work
show
bind
pact
prevent
pact
bind
rigi
inhibit
rigi
activ
luthra
et
al
bind
pact
mediat
central
basic
patch
iid
abrog
dsrna
bind
describ
suggest
possibl
role
dsrna
interact
surprisingli
pact
interact
inhibit
bind
l
caus
decreas
effici
viral
rna
synthesi
genom
replic
phenotyp
mutual
antagon
luthra
et
al
taken
togeth
previou
data
experi
point
critic
import
antagon
rigi
pathway
ebolaviru
infect
addit
interact
cellular
protein
explor
use
yeast
twohybrid
system
studi
found
interact
chang
et
al
key
compon
small
ubiquitinrel
modifi
sumo
system
posttransl
modif
regul
varieti
cellular
pathway
protein
sumoyl
sumo
protein
activ
sumospecif
proteas
transfer
sumoconjug
enzym
eg
next
ligas
use
transfer
sumo
domain
lysin
target
protein
wimmer
et
al
studi
ebola
found
abl
block
cpginduc
interferon
induct
involv
pathway
subsequ
investig
reveal
abl
sumoyl
express
enhanc
sumoyl
lead
suppress
activ
decreas
interferon
promot
activ
similar
find
note
follow
express
chang
et
al
thu
sumoyl
lead
reduct
interferon
ab
gene
transcript
arenavirus
eg
lassa
lcmv
taken
similar
multiprong
approach
prevent
type
interferon
respons
lassa
hemorrhag
fever
mani
characterist
similar
ebola
viru
diseas
includ
absenc
interferon
product
lymphoid
deplet
molecular
level
arenavirus
shown
suppress
interferon
product
target
upstream
ie
downstream
signal
event
ie
interact
phosphoryl
koma
et
al
way
viru
disrupt
multipl
access
point
pathway
lead
increas
interferon
product
given
similar
clinic
syndrom
common
approach
interferon
antagon
investig
may
provid
insight
underli
pathogen
mechan
hemorrhag
fever
syndrom
innat
immun
intact
host
respons
viru
infect
caus
secret
interferon
order
gener
antivir
respons
neighbor
cell
signal
hematopoiet
cell
respons
increas
antigen
present
secret
interferon
bind
type
ii
interferon
receptor
induc
signal
via
adaptor
protein
result
phosphoryl
subsequ
dimer
signal
transduc
activ
transcript
stat
protein
eg
next
dimer
phosphoryl
stat
transport
nucleu
bind
interferon
respons
element
induc
gene
express
ivashkiv
donlin
platania
given
import
pathway
induc
antivir
gene
express
respons
interferon
commonli
target
virus
exampl
dengu
viru
block
phosphoryl
act
degrad
via
proteasom
degrad
pathway
green
et
al
earli
experi
ebola
found
viru
block
product
interferon
also
inhibit
cellular
respons
normal
result
interferon
ab
type
interferon
g
type
ii
signal
signal
block
associ
express
ebola
protein
later
shown
prevent
nuclear
accumul
dimer
phosphoryl
reid
et
al
particip
type
ie
phosphorylateddim
type
ii
phosphorylateddim
signal
propag
cascad
ivashkiv
donlin
platania
phosphoryl
dimer
transport
nucleu
mediat
interact
member
nucleoprotein
interactor
famili
ie
karyopherina
bind
nuclear
local
signal
nl
cargo
destin
nucleu
downstream
interact
karyopherinb
protein
allow
cargo
cross
nuclear
membran
unlik
nuclear
protein
dimer
phosphoryl
interact
karyopherina
uniqu
noncanon
nl
allow
preferenti
access
nucleu
biochem
structur
studi
shown
bind
karyopherina
noncanon
nlsbind
domain
block
phosphoryl
dimer
transport
nucleu
furthermor
bind
karyopherina
appear
block
access
canon
nlsbind
site
mateo
et
al
reid
et
al
xu
et
al
therefor
viru
interfer
type
type
ii
interferon
signal
without
disrupt
routin
traffick
nucleu
infect
cell
unphosphoryl
abl
enter
nucleu
use
karyopherinaindepend
mechan
abl
induc
prolong
express
interferoninduc
immun
regulatori
gene
cheon
stark
meyer
vinkemei
biochem
structur
studi
ctermin
truncat
mutant
demonstr
bind
effici
lack
tyrosin
target
phosphoryl
suggest
addit
mechan
unrel
phosphoryl
dimer
nuclear
transport
abl
inhibit
induct
interferon
respons
ie
block
action
form
addit
jakstat
pathway
type
interferon
receptor
signal
map
kinas
pathway
signal
cascad
map
kinas
result
phosphoryl
ivashkiv
donlin
platania
one
studi
found
abl
block
interferonbinduc
phosphoryl
cell
howev
find
cell
type
specif
block
mechan
yet
demonstr
gener
cell
primari
target
infect
eg
macrophag
dendrit
cell
halfmann
et
al
like
link
ebola
pathogenesi
particular
experi
use
mouseand
guineapigadapt
variant
ebola
demonstr
conjunct
protein
np
critic
viru
lethal
cilloniz
et
al
ebihara
et
al
mateo
et
al
reid
et
al
structur
analysi
comparison
sudan
reston
identifi
two
conserv
structur
pocket
contain
residu
implic
pathogenesi
solvent
exchang
studi
show
region
may
near
propos
region
suggest
may
play
role
bind
pathogenesi
taken
togeth
previou
studi
karyopherina
play
role
pathogenesi
disrupt
type
type
ii
interferon
signal
thu
ebola
diminish
interferon
alarm
also
inhibit
alarm
respons
heard
coordin
approach
lead
highli
effect
antagon
innat
immun
respons
mediat
interferon
silenc
fall
disrupt
rnai
respons
infect
cell
rna
virus
activ
rnaspecif
inhibit
rnai
pathway
host
cell
silenc
viral
gene
express
cleav
viral
rna
small
interf
rna
sirna
bind
disrupt
complementari
rna
transcript
tat
thought
suppress
rnai
respons
block
dicer
activ
key
compon
rna
silenc
complex
ebola
suppress
cellular
rnai
silenc
complement
tat
mutant
suppress
lost
mutat
made
dsrnabind
domain
suggest
may
bind
sirna
dsrna
precursor
sirna
haasnoot
et
al
though
subsequ
studi
found
ctermin
domain
bound
sirna
dsrna
rnai
silenc
suppress
activ
correl
bind
sirna
hypothes
suppress
via
rnabindingindepend
mechan
could
instead
occur
bind
risc
complex
sequestr
risc
complex
protein
prior
incorpor
complex
zhu
et
al
theori
support
prior
experi
found
interact
transactiv
respons
rnabind
protein
trbp
pact
fabozzi
et
al
compon
risc
rnai
complex
thu
propos
mediat
rnasilenc
suppressor
activ
interestingli
anoth
ebola
protein
also
bind
compon
risc
complex
act
suppressor
rnai
silenc
fabozzi
et
al
similar
ebola
tactic
interferon
antagon
viru
use
two
differ
viral
protein
disrupt
mammalian
rnai
innat
immun
respons
host
cell
thwart
viral
infect
decreas
cellular
protein
synthesi
effort
prevent
slow
viral
replic
accomplish
doublestrand
rnadepend
protein
kinas
pkr
upon
bind
dsrna
activ
pkr
phosphoryl
subunit
eukaryot
translat
initi
ebola
express
shown
block
pkr
activ
enhanc
express
protein
cell
treat
type
interferon
block
pkr
impair
phosphoryl
pkr
current
data
suggest
effect
mediat
iid
domain
howev
work
elucid
molecular
mechan
requir
feng
et
al
mann
et
al
heterogen
nuclear
protein
complex
protein
hnrnp
typic
found
nucleu
bind
polyu
region
mrna
assist
splice
prior
mrna
export
cytoplasm
also
shown
particip
capindepend
iresdepend
translat
cytoplasm
mitosi
shabman
et
al
sever
virus
includ
dengu
polioviru
found
coopt
function
mean
enhanc
viral
protein
synthesi
replic
brunner
et
al
brunner
et
al
noisakran
et
al
pettit
kneller
et
al
likewis
ebola
express
caus
reloc
hnrnp
nucleu
cytoplasm
interestingli
hnrnp
also
bind
karyopherina
via
noncanon
nl
sequenc
use
suggest
possibl
mechan
redistribut
hypothes
ebola
genom
mrna
sequenc
contain
mani
polyu
tract
hnrnp
may
interact
ebola
rna
stabil
viral
mrna
enhanc
genom
replic
shabman
et
al
thu
pkr
inhibit
hnrnp
reloc
ebolavirus
coopt
cellular
machineri
optim
translat
gene
product
potenti
prolong
halflif
viral
messeng
genom
rna
tetherin
type
interferoninduc
cellular
factor
shown
prevent
envelop
viru
bud
plasma
membran
tetherin
contain
two
membraneanchor
domain
thought
mediat
inhibit
bud
anchor
cellular
viral
membran
neil
et
al
tetherin
first
describ
antagon
retroviru
particl
bud
studi
found
particl
bud
rescu
express
vpu
neil
et
al
ebola
viruslik
particl
vlp
made
presenc
overexpress
tetherin
similar
decreas
vlp
releas
note
simultan
express
vpu
rescu
particl
releas
vlp
without
gp
express
show
gp
antagon
tetherin
activ
coimmunoprecipit
tetherin
kaletski
et
al
recent
experi
suggest
residu
within
transmembran
domain
gp
contribut
gpdepend
tetherin
antagon
et
al
hl
et
al
mechan
propos
gptetherin
antagon
includ
interfer
tetherin
integr
steric
hindranc
gp
interfer
format
tetherin
connect
viral
cellular
membran
gpdepend
exclus
tetherin
region
plasma
membran
ebola
viru
particl
bud
kaletski
et
al
vpu
mediat
cellsurfac
downregul
reloc
degrad
tetherin
lopez
et
al
howev
ebola
gp
appear
downregul
alter
tetherin
local
lopez
et
al
lopez
et
al
suggest
novel
antitetherin
mechan
tradeoff
effici
viral
replic
pathogen
delic
balanc
mismatch
lead
host
demis
therefor
virus
evolv
suppress
immun
respons
select
regul
manner
facilit
control
viru
replic
progeni
transmiss
section
highlight
two
interferoninduc
gene
date
known
directli
counter
ebola
infect
lead
decreas
viru
infect
interferoninduc
transmembran
protein
ifitm
broadli
activ
interferonrespons
restrict
factor
first
describ
inhibitor
influenza
shown
activ
mani
envelop
virus
includ
ebola
cousin
marburg
viru
huang
et
al
ifitm
found
multipl
membran
surfac
along
cellular
uptak
pathway
propos
act
block
viru
entri
huang
et
al
perreira
et
al
sever
antivir
mechan
propos
includ
cholesterol
accumul
inhibit
back
fusion
viru
contain
vesicl
multivesicular
bodi
chang
membran
fluid
dynam
alter
membran
curvatur
ie
restrict
capac
fusion
viru
cellular
membran
aminibavil
olyae
et
al
perreira
et
al
recent
experi
influenza
viru
suggest
act
block
yet
undefin
step
viruscel
membran
hemifus
fusion
pore
format
desai
et
al
thu
allow
viru
celluar
membran
lipid
mix
allow
format
complet
fusion
pore
prevent
ribonucleoprotein
core
viru
gain
access
cytoplasm
block
infect
futur
experi
need
perform
determin
whether
mechan
applic
ebola
envelop
virus
ie
arenavirus
abl
avoid
restrict
ifitm
anoth
interferonstimul
gene
block
ebola
infect
broadli
activ
antivir
gene
product
conjug
target
protein
caus
alter
target
protein
activ
cellular
locat
stabil
shown
affect
mani
virus
includ
influenza
ab
hepat
b
herp
simplex
type
lcmv
ebola
harti
et
al
case
ebola
antivir
activ
link
disrupt
bud
use
vlp
assay
ebola
bud
part
mediat
ubiquitin
two
group
found
interact
prevent
ubiquitin
lead
ineffici
particl
bud
liu
harti
thu
togeth
ifitm
tetherin
observ
suggest
interferonstimul
gene
potent
antivir
activ
target
ebolaviru
entri
egress
resist
freshli
isol
monocyt
ebola
illustr
one
exampl
factor
may
play
role
infect
experi
ebola
gppseudotyp
vlp
found
particl
abl
bind
enter
freshli
isol
monocyt
howev
monocyt
underw
differenti
previous
bound
vlp
abl
enter
monocyt
result
recapitul
use
replic
ebola
virus
martinez
et
al
detail
analysi
found
monocyt
matur
ifitm
downregul
cystein
proteas
cathepsin
b
express
upregul
find
demonstr
ifitm
restrict
factor
might
play
role
rel
resist
infect
interferonactiv
cell
also
confirm
import
ebola
infect
balanc
scale
immun
respons
paradox
ebola
viru
diseas
surviv
mortal
link
gener
strong
immun
signal
respons
host
survivor
asymptomat
patient
increas
number
cell
earli
cytotox
tcellmedi
respons
baiz
et
al
sanchez
et
al
wauquier
et
al
rapid
uptak
ebola
macrophag
dendrit
cell
result
transloc
lymphoid
peripher
tissu
also
may
explain
deficit
nonsurvivor
inflammatori
cytokin
secret
need
earli
exposur
control
infect
experi
use
invitrocultur
monocytederiv
macrophag
found
ebola
infect
inhibit
secret
tnfa
consist
impair
observ
associ
fatal
diseas
outcom
mahanti
et
al
furthermor
dendrit
cell
expos
either
live
inactiv
viru
fail
upregul
molecul
need
tcell
costimul
result
inhibit
tcell
prolifer
studi
use
blood
sampl
obtain
infect
human
subject
found
tnfa
respons
higher
survivor
nonsurvivor
earli
time
point
later
time
point
remain
higher
survivor
differ
nonsurvivor
less
dramat
due
increas
latter
group
contrast
tnfa
nonsurvivor
much
higher
survivor
late
diseas
onset
interest
note
may
play
critic
role
modul
respons
although
mildli
elev
survivor
like
feedback
mechan
control
inflammatori
respons
increas
short
live
would
expect
cytokin
level
return
normal
howev
higher
fatal
case
remain
elev
death
addit
monocytemacrophag
activ
measur
neopterin
level
higher
consist
elev
fatal
case
baiz
et
al
leroy
et
al
leroy
et
al
suggest
unregul
immun
activ
though
recent
studi
show
differ
pattern
specif
cytokin
wauquier
et
al
gener
trend
toward
survivor
shortliv
balanc
proand
antiinflammatori
respons
nonsurvivor
delay
prolong
inflammatori
respons
lead
cytokin
storm
togeth
observ
suggest
subject
abl
overcom
innat
immun
respons
block
like
establish
earli
balanc
benefici
secret
proinflammatoryantiinflammatori
cytokin
contrast
earli
host
antivir
innat
respons
block
uncontrol
viru
replic
lysi
hematopoiet
cell
lead
late
unbalanc
cytokin
releas
overal
dysregul
immun
respons
develop
advanc
ebola
viru
diseas
fatal
irrevers
consequ
hematopoiet
cell
destruct
ebola
reduc
antigen
present
outcom
consist
observ
poor
igg
respons
fatal
infect
wherea
high
level
igg
associ
surviv
baiz
et
al
ksiazek
et
al
compound
inhibit
igg
product
ebola
evolv
multipl
properti
could
circumv
antibodi
effect
larg
filament
virion
contain
highdens
stabl
glycoprotein
present
potenti
obstacl
effici
inhibit
antibodi
viru
filament
fold
may
creat
pocket
glycoprotein
inaccess
antibodi
bind
furthermor
heavi
glycosyl
mucinlik
domain
gp
may
limit
access
critic
epitop
requir
effici
neutral
martinez
et
al
antibodi
access
restrict
due
rapid
virion
uptak
via
macropinocytosi
intracellular
receptor
bind
addit
ebolaviru
hide
critic
receptor
bind
domain
beneath
glycan
cap
exposur
receptor
bind
occur
cathepsinmedi
remov
cap
protect
critic
function
domain
analog
hiv
engag
requir
expos
coreceptorbind
site
harrison
furthermor
use
intracellular
receptor
novel
immun
evas
strategi
may
import
virus
eg
lassa
fever
viru
jae
et
al
addit
membraneanchor
gp
glycoprotein
gene
ebola
encod
sgp
aa
protein
ident
gp
ntermin
residu
secret
infect
cell
present
virion
default
transcript
glycoprotein
gene
surprisingli
virionassoci
gp
trimer
instead
dimer
sgp
balanc
express
two
protein
govern
polymeras
stutter
rnaedit
site
led
specul
sgp
function
modul
misdirect
host
immun
respons
kindzelskii
et
al
yang
et
al
best
evid
hypothesi
come
recent
paper
show
mice
sgp
promot
immun
evas
serv
antibodi
decoy
gp
present
altern
nonneutr
antibodi
epitop
humor
immun
respons
mohan
et
al
remark
evid
suggest
glycoprotein
gene
express
sgp
may
due
part
select
pressur
seek
balanc
toxic
due
cytopath
effect
gp
requir
gp
viru
particl
avoid
host
immun
respons
direct
gp
taken
togeth
data
suggest
ebola
express
sgp
gp
tightli
regul
process
immun
shield
viru
particl
product
balanc
via
rna
edit
addit
immun
evas
achiev
virion
gp
structur
characterist
gp
exhibit
direct
immunosuppress
properti
chepurnov
et
al
sgp
interact
neutrophil
disrupt
linkag
fc
g
riiib
kindzelskii
et
al
furthermor
ebola
transmembran
glycoprotein
bear
structur
similar
retrovir
glycoprotein
possess
immunosuppress
peptid
motif
volchkov
et
al
found
inhibit
lymphocyt
activ
prolifer
yaddanapudi
et
al
particular
interest
observ
analog
immunosuppress
peptid
reston
viru
inhibitori
macaqu
human
peripher
blood
cell
implic
motif
ebola
pathogen
studi
measur
vivo
antigenspecif
tcell
respons
limit
difficulti
obtain
preserv
viabl
lymphocyt
sampl
ebolainfect
subject
survivor
nonetheless
data
suggest
cours
ebola
viru
diseas
dramat
decreas
absolut
number
cell
due
bystand
apoptosi
impair
direct
cellmedi
kill
virusinfect
cell
tcelldepend
antivir
antibodi
respons
sanchez
et
al
indirect
measur
tcell
function
base
serum
cytokin
level
rna
express
isol
lymphocyt
suggest
immunoglobulin
level
associ
intact
cellmedi
immun
surviv
baiz
et
al
ksiazek
et
al
sanchez
et
al
wauquier
et
al
macaqu
cell
essenti
vaccineinduc
immun
protect
stanley
et
al
sullivan
et
al
humor
respons
clearli
play
benefici
role
contain
viru
requir
protect
ebola
speci
hensley
et
al
stanley
et
al
sullivan
et
al
antibodi
particip
effect
viru
clearanc
like
requir
presenc
intact
host
cellmedi
respons
wong
et
al
one
specul
interpret
human
macaqu
data
immunoglobulin
innat
immun
respons
particip
contain
earli
viral
load
cellmedi
immun
need
effici
viru
clearanc
interplay
necess
broad
immun
respons
mechan
also
suggest
ebola
evolut
strategi
counteract
host
antivir
defens
taken
togeth
data
suggest
complex
interplay
proand
antiinflammatori
factor
result
either
balanc
immun
respons
host
surviv
dysregul
death
fatal
ebola
infect
mark
catastroph
failur
innat
adapt
immun
mediat
virusencod
protein
well
properti
associ
viru
structur
heart
ebolainduc
immun
dysregul
multiprong
attack
host
antivir
immun
earli
coordin
disrupt
host
innat
respons
lead
elev
level
viru
replic
cascad
inappropri
time
cytokin
releas
death
antigenpres
respond
immun
cell
figur
result
poorli
activ
adapt
immun
respons
compromis
induct
lymphocyt
apoptosi
antibodi
decoy
mechan
incident
host
multifacet
approach
subvers
immun
system
result
high
mortal
would
expect
limit
viru
persist
absenc
distinct
reservoir
speci
sinc
first
identifi
almost
year
ago
genom
ebola
shown
remark
stabil
unusu
featur
rna
virus
errorpron
polymeras
suggest
ebola
highli
adapt
reservoir
host
one
intrigu
hypothesi
addit
host
restrict
factor
limit
pathogen
natur
reservoir
speci
factor
would
play
role
balanc
immun
sustain
viral
replic
allow
viru
propag
persist
time
reservoir
speci
outsid
reservoir
sustain
larg
outbreak
one
west
africa
may
lead
ebolaviru
adapt
observ
longitudin
result
alter
pathogen
viru
adapt
human
overal
multifacet
approach
ebola
select
regul
immun
respons
variabl
pathogen
differ
host
speci
make
viru
scientif
interest
challeng
foe
